Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications understanding treatment preferences patients kras pg12clc1 mk2 ��� mutated advanced non
… Strategic collaboration follows RTI’s equity investment in advanced tech-enabled research services RESEARCH TRIANGLE … Agreement will provide clients with the opportunity to use advanced tech-enabled research services by leveraging the …
… In 2003, the drug received approval from the FDA for the treatment of glucocorticoid-induced osteoporosis in … for the case-finding study. RTI-HS interviewed patients about any prior use of FORTEO®, other medications … risk factors. In the other studies, Information on FORTEO® patients (and in two studies, comparator patients) was linked …
… Characteristics of and healthcare cost drivers among U.S. patients with eosinophilic esophagitis with high versus non-high all-cause costs: an analysis of insurance claims …
… in applying stated-preference methods to elicit the preferences of patients and other healthcare decision-makers. Her most … and Value research theme. She has over 50 peer-reviewed publications in journals that include Journal of Health …
… research methods to understand the experiences and preferences of people accessing healthcare services. Dr. … research was to contribute to a better distribution of treatment resources and improved access for people seeking drug and alcohol treatment in Australia. Prior to joining RTI-HS, Richard …
… Share on: January 18, 2024 Improving Health Equity with Advanced Data Science Methods and Geospatial Analytics … SDOH database that merges artificial intelligence (AI) and advanced spatial analytics in a risk-adjustment framework. …
… systematic literature review (SLR), and indirect treatment comparisons, these services should include advanced estimation of likely PICOs and timely updates of … will be essential - including early dialogues with patients, caregivers, payers, and HTA opinion leaders. …
Joint Clinical Assessment Support Get Ready for Your 100-Day Sprint With only 100 days between confirmation of the Population, Intervention, Comparator(s) and Outcomes (PICOs) and dossier submission, companies getting prepared now will be in the best …
… in blood cancer and across cancers on preference for treatment administration, presenting at ISPOR, Health …
… many types of statistical analyses, such as mixed-treatment comparison meta-analyses, database analyses in the … human mutation in cancer and genetic disease, and an understanding of all aspects of the clinical trial process …